JULY 2021 - FINEXSI ISSUED ITS REPORT AS INDEPENDENT EXPERT IN CONNECTION WITH THE PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT (OPR-RO) INITIATED BY CALLIDITAS THERAPEUTICS AB FOR THE SHARES OF GENKYOTEX S.A.

FINEXSI – Mandataire / Monitoring trustee – Fret SNCF – Coordonnées de contact

X